Innocan Pharma Moves Forward with Significant Debenture Offering to Tamar Innovest Innocan Pharma announces a new debenture offering to Tamar Innovest, aiming for $200,000 in funding while bolstering its corporate structure.

Innocan Pharma Moves Forward with Significant Debenture Offering to Tamar Innovest #Innocan_Pharma #Tamar_Innovest #Debenture_Offering

BioVaxys Announces Successful Closure of Convertible Debenture Offering BioVaxys Technology Corp. has completed its non-brokered private placement of unsecured convertible debentures, raising $335,670 for advancing its projects.

BioVaxys Announces Successful Closure of Convertible Debenture Offering #Canada #Vancouver #biotechnology #BioVaxys #Debenture_Offering

Agibank Secures BRL 4 Billion to Enhance Funding Strategy and Growth Agibank has successfully raised BRL 4 billion through a unique debenture offering, aimed at optimizing its capital structure and supporting sustainable growth.

Agibank Secures BRL 4 Billion to Enhance Funding Strategy and Growth #Brazil #São_Paulo #Debenture_Offering #Agibank #BRL_4_billion

Innocan Pharma Concludes Significant Debenture Unit Offering with Tamar Innovest Limited Innocan Pharma has finalized a $1 million debenture unit offering to its primary shareholder, Tamar Innovest, enhancing its funding and growth prospects.

Innocan Pharma Concludes Significant Debenture Unit Offering with Tamar Innovest Limited #Canada #Calgary #Innocan_Pharma #Tamar_Innovest #Debenture_Offering

Innocan Pharma Seeks $1 Million from Tamar Innovest via Debenture Unit Offering Innocan Pharma Corporation has announced a private placement of a debenture unit targeting Tamar Innovest, aiming to raise $1 million for corporate needs.

Innocan Pharma Seeks $1 Million from Tamar Innovest via Debenture Unit Offering #Canada #Calgary #Innocan_Pharma #Tamar_Innovest #Debenture_Offering